A new approach helps examine the proportion of cancerous and healthy stem cells in patients with chronic myeloid leukemia and how this influences treatment outcomes.
As of 2022, more than 800 new cell therapies are being developed for five blood cancers, with the market for oncology cell therapies expected to exceed $37 billion in value globally by 2028.
An expert discussed the findings of the COMMANDS trial evaluating Reblozyl’s role in red blood cell transfusion independence for patients with MDS. With my myelodysplastic syndrome and age, I find it ...
Blood cancer is not always fatal and advancements in treatment offer significant hope. Misconceptions exist, such as it being a result of poor lifestyle choices or only affecting older adults.
Read more about childhood cancers. Dr Charlotte Pawlyn and Dr Martin Kaiser are leading laboratory research teams and clinical trials of new treatments for myeloma, a type of blood cancer that ...
Blood cancer, also known as hematologic cancer, encompasses a variety of cancers affecting blood, bone marrow, and lymphatic ...
Cell division is a pivotal moment in the life cycle of a cell: when things go wrong, the cell typically triggers growth arrest or its own self-destruction. Researchers have now discovered a previously ...
Polycythemia vera (PV) is a blood cancer that begins in the marrow of your bones, the soft center where new blood cells grow. It causes your marrow to make too many red blood cells so your blood ...
The evolution of pancreatic cancer screening technologies is pivotal for early detection, addressing key challenges to ...
And it has struggled to have any success in "solid cancers" - those that form tumours rather than blood cancers such as leukaemia. The researchers say their T-cell receptor could lead to a ...
The study suggests non-fermented milk may raise ischemic heart disease risk in women, urging a closer look at dairy ...
Blood cancer, or hematologic cancer, affects blood cells, bone marrow, and lymphatic system. It includes leukemia, lymphoma, ...